Development of immunodrug for the treatment of human cervical carcinoma and characterization of the target antigen
博士 === 國防醫學院 === 醫學研究所 === 79 ===
Main Authors: | YU,MU-XIAN, 余慕賢 |
---|---|
Other Authors: | YE,MING-YANG |
Format: | Others |
Language: | zh-TW |
Published: |
1991
|
Online Access: | http://ndltd.ncl.edu.tw/handle/45655359282217981186 |
Similar Items
-
Genomic Characterization and Therapeutic Targeting of HPV Undetected Cervical Carcinomas
by: Fiona J. Ruiz, et al.
Published: (2021-09-01) -
Role of squamous cell carcinoma antigen in monitoring of treatment response of cervical and vaginal malignancies
by: Rekha Sachan, et al.
Published: (2017-01-01) -
Ovarian carcinoma glyco-antigen targeted by human IgM antibody.
by: Yi Chen, et al.
Published: (2017-01-01) -
Human leukocyte antigen types and sister chromatid exchange frequencies in familially aggregated and sporadic cases of nasopharyngeal carcinoma
by: WU, XIAN-BANG, et al.
Published: (1987) -
The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
by: Li Hua-Bin, et al.
Published: (2009-09-01)